Ivanov, A.M.,
Gil'manov, A.Z.,
Malyutina, N.N.,
Khovaeva, Y.B.,
Nenasheva, O.Y.,
El'kin, G.I.,
Sosnin, D.Y. (2020) . Heterozygote state prevailed for genes of
methionine synthase reductase and folate transport protein among
Fedorova, Yu. Yu.,
Nurgalieva, A.K.,
Petrova, S.G.,
Murzina, R.R.,
Dzhaubermezov, M.A.,
Ekomasova, N.V.,
Khusnutdinova, E.K.,
Prokofieva, D.S. (2024) 1801133 (677C > T), rs1801131 (1298A > C)) and
methionine synthase reductase MTRR (rs1801394 (66A > G
WANG, K.,
LIU, H.,
LIU, J.,
WANG, X.,
TENG, L.,
ZHANG, J.,
CHEN, X.,
WANG, N.,
ZHONG, Y.,
HOU, X.,
JIANG, H.,
ZHANG, X.,
ZHAO, S.,
LIU, Y.,
YAO, Y.,
WANG, J.,
QU, Y.,
PENG, F.,
BEYLERLI, O.,
LIAO, X. (2019) , the molecular mechanisms underlying metabolic reprogramming induced by
methionine deprivation regulates glioma
Thymidylate
synthase (ThS) is a target for antimetabolite antitumor drugs. Such drugs have been
Thymidylate
synthase (ThS) is a target for antimetabolite antitumor drugs. Such drugs have been
and quinazolin-4-imine derivatives, well-known antifolate thymidylate
synthase (TYMS) inhibitors, has been
Baltina, L. A.,
Sapozhnikova, T. A.,
Gabdrakhmanova, S. F.,
Makara, N. S.,
Khisamutdinova, R. Yu.,
Baltina, L. A. Jr.,
Petrova, S. F.,
Saifullina, D. R.,
Kondratenko, R. M. (2021) -dilithium salts (III), and a conjugate with L-
methionine methyl ester (IV) was studied using an alloxan diabetes
Ligacheva, A.A.,
Sherstoboev, E.Y.,
Danilets, M.G.,
Trofimova, E.S.,
Krivoshchekov, S.V.,
Gur’ev, A.M.,
Bulgakov, T.V.,
Kudashkina, N.V.,
Miroshnichenko, A.G.,
Belousov, M.V. (2020) macrophage culture induces classical activation of antigen-presenting cells due to an increase in NO
synthaseLigacheva, A.A.,
Sherstoboev, E.Y.,
Danilets, M.G.,
Trofimova, E.S.,
Krivoshchekov, S.V.,
Khasanova, S.R.,
Kudashkina, N.V.,
Gur’ev, A.M.,
Belousov, M.V. (2021) -presenting cells by increasing NO
synthase activity and reducing arginase expression. © 2021, Springer Science